Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,600 | 270 | 96.8% |
| Education | $184.99 | 2 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $1,400 | 37 | $0 (2024) |
| Astellas Pharma US Inc | $845.82 | 53 | $0 (2023) |
| ABBVIE INC. | $635.67 | 36 | $0 (2024) |
| Boston Scientific Corporation | $319.66 | 14 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $168.49 | 7 | $0 (2023) |
| Blue Earth Diagnostics Limited | $154.74 | 6 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $154.13 | 10 | $0 (2023) |
| COLOPLAST CORP | $135.84 | 8 | $0 (2024) |
| Mission Pharmacal Company | $133.90 | 9 | $0 (2024) |
| Medtronic USA, Inc. | $131.85 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $939.58 | 39 | Medtronic, Inc. ($240.47) |
| 2023 | $1,130 | 46 | Medtronic, Inc. ($261.71) |
| 2022 | $1,178 | 51 | Medtronic, Inc. ($605.31) |
| 2021 | $1,051 | 53 | Medtronic, Inc. ($292.97) |
| 2020 | $349.51 | 16 | Medtronic USA, Inc. ($131.85) |
| 2019 | $365.14 | 19 | Astellas Pharma US Inc ($157.75) |
| 2018 | $450.96 | 26 | Astellas Pharma US Inc ($80.06) |
| 2017 | $321.02 | 22 | Astellas Pharma US Inc ($162.62) |
All Payment Transactions
272 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | COLOPLAST CORP | Altis (Device) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Women's Health | ||||||
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/09/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/21/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $116.33 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/28/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: Diagnostic Imaging | ||||||
| 10/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/13/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $48.72 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/10/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/09/2024 | COLOPLAST CORP | Coloplast TFL Drive (Device) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Endourology | ||||||
| 08/26/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Diagnostic Imaging | ||||||
| 08/23/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $38.97 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/21/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: HORMONE THERAPY | ||||||
| 07/29/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: ONCOLOGY | ||||||
| 07/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/02/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/01/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: UROTHELIAL CANCER | ||||||
| 06/21/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 06/20/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Immunotherapy | ||||||
| 06/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/05/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: ONCOLOGY | ||||||
| 05/22/2024 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: ONCOLOGY | ||||||
| 05/08/2024 | COLOPLAST CORP | Luja Coude (Device) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Continence Care | ||||||
| 05/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/01/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,164 | 1,666 | $448,105 | $131,659 |
| 2022 | 19 | 1,185 | 1,702 | $476,843 | $133,023 |
| 2021 | 21 | 1,191 | 1,752 | $416,100 | $139,442 |
| 2020 | 21 | 1,209 | 1,619 | $357,090 | $123,676 |
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 326 | 424 | $86,920 | $40,526 | 46.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 29 | 226 | $169,500 | $30,564 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 281 | 341 | $49,445 | $20,432 | 41.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 61 | $17,690 | $8,582 | 48.5% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 12 | 15 | $12,750 | $4,990 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $8,910 | $4,066 | 45.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 47 | 56 | $25,200 | $3,681 | 14.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 56 | $8,400 | $3,633 | 43.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 27 | $7,425 | $2,885 | 38.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $6,120 | $2,535 | 41.4% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 13 | 51 | $7,650 | $2,453 | 32.1% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 13 | 13 | $9,100 | $1,605 | 17.6% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 13 | 13 | $19,500 | $1,379 | 7.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 120 | 147 | $7,056 | $1,222 | 17.3% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 28 | 41 | $3,280 | $1,169 | 35.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 44 | 53 | $2,915 | $842.34 | 28.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 15 | $1,800 | $612.45 | 34.0% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 13 | 13 | $3,504 | $323.18 | 9.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 43 | 47 | $940.00 | $160.27 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 287 | 385 | $91,245 | $37,245 | 40.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 21 | 198 | $148,500 | $28,054 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 342 | 394 | $68,835 | $24,950 | 36.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 69 | 92 | $30,905 | $12,787 | 41.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 51 | 60 | $27,000 | $3,990 | 14.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $10,695 | $3,910 | 36.6% |
About Dr. Albert Ruenes, M.D
Dr. Albert Ruenes, M.D is a Specialist healthcare provider based in Doylestown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1831193226.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Albert Ruenes, M.D has received a total of $5,785 in payments from pharmaceutical and medical device companies, with $939.58 received in 2024. These payments were reported across 272 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($5,600).
As a Medicare-enrolled provider, Ruenes has provided services to 4,749 Medicare beneficiaries, totaling 6,739 services with total Medicare billing of $527,800. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Urology
- Location Doylestown, PA
- Active Since 06/13/2005
- Last Updated 10/28/2020
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1831193226
Products in Payments
- INTERSTIM (Device) $1,532
- BOTOX (Biological) $320.06
- LUPRON DEPOT (Drug) $278.67
- Myrbetriq (Drug) $258.21
- MYRBETRIQ (Drug) $240.61
- LITHOVUE (Device) $171.11
- Nubeqa (Drug) $168.49
- XTANDI (Drug) $159.39
- ORGOVYX (Drug) $137.05
- iTIND System (Device) $120.63
- POSLUMA (Drug) $109.01
- XIAFLEX (Biological) $102.82
- GEMTESA (Drug) $92.93
- UROLIFT (Device) $92.07
- Xtandi (Drug) $88.64
- ILLUCCIX (Drug) $87.92
- Uribel (Drug) $72.13
- KEYTRUDA (Biological) $71.77
- Noctiva (Drug) $69.80
- JELMYTO (Drug) $67.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Doylestown
Dr. Alan Chang, Md, MD
Specialist — Payments: $14,797
Mr. Kieran Cody, M.d, M.D
Specialist — Payments: $12,112
Melchiore Vernace, M.d, M.D
Specialist — Payments: $8,914
Daniel Lin, M.d, M.D
Specialist — Payments: $7,571
Dr. Kevin Fitzgerald, M.d, M.D
Specialist — Payments: $6,732
Dr. Louis Morsbach, M.d, M.D
Specialist — Payments: $6,358